SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-17-002539
Filing Date
2017-03-17
Accepted
2017-03-17 06:29:08
Documents
18
Period of Report
2017-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp74084_6k.htm 6-K 15518
2 EXHBIIT 99.1 dp74084_ex9901.htm EX-99.1 41056
3 EXHIBIT 99.2 dp74084_ex9902.htm EX-99.2 192520
4 EXHIBIT 99.3 dp74084_ex9903.htm EX-99.3 106041
5 GRAPHIC image_001.jpg GRAPHIC 2717
6 GRAPHIC image_002.jpg GRAPHIC 3580
7 GRAPHIC image_003.jpg GRAPHIC 2055
8 GRAPHIC image_007.jpg GRAPHIC 249372
9 GRAPHIC image_008.jpg GRAPHIC 5889
10 GRAPHIC image_009.jpg GRAPHIC 2719
11 GRAPHIC image_010.jpg GRAPHIC 1412
12 GRAPHIC image_011.jpg GRAPHIC 1868
13 GRAPHIC image_012.jpg GRAPHIC 1207
14 GRAPHIC image_013.jpg GRAPHIC 1533
15 GRAPHIC image_014.jpg GRAPHIC 7125
16 GRAPHIC image_002.gif GRAPHIC 1303
17 GRAPHIC image_003.gif GRAPHIC 1387
18 GRAPHIC image_004.gif GRAPHIC 1133
  Complete submission text file 0000950103-17-002539.txt   747327
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 17696298
SIC: 2834 Pharmaceutical Preparations